Literature DB >> 28605256

Adolescent human papillomavirus vaccination in the United States: Opportunities for integrating pharmacies into the immunization neighborhood.

Joseph P Fava1, Jacob Colleran1, Francesca Bignasci1, Raymond Cha1, Paul E Kilgore1.   

Abstract

Human Papillomavirus (HPV) vaccination faces several barriers, including a social stigma which carries religious and philosophical implications among parents of adolescents as well as young adults. Hundreds of immunization interventions and programs have been developed to address these factors and boost HPV vaccination rates in the United States. We sought to review the existing literature highlighting barriers to HPV immunization, as well as programs targeting increased HPV vaccine uptake in effort to develop novel vaccination initiatives. The most impactful barriers identified were parental stigma and low quality of provider recommendations for the vaccine. Despite the implementation of many HPV initiatives, outcomes of these programs are largely limited to modest improvements in vaccine uptake in small, homogeneous populations. We describe pharmacies as distinctly advantageous but underutilized resources within the immunization neighborhood and propose a novel concept to improve vaccination rates as well as reduce HPV-related disease burden in all demographics.

Entities:  

Keywords:  HPV; adolescent; barriers; immunization; initiatives; pharmacy; vaccination

Mesh:

Substances:

Year:  2017        PMID: 28605256      PMCID: PMC5557233          DOI: 10.1080/21645515.2017.1325980

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  71 in total

Review 1.  Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types.

Authors:  Edward P Armstrong
Journal:  J Manag Care Pharm       Date:  2010-04

2.  A cost-effectiveness analysis of human papillomavirus vaccination of boys for the prevention of oropharyngeal cancer.

Authors:  Donna M Graham; Wanrudee Isaranuwatchai; Steven Habbous; Claire de Oliveira; Geoffrey Liu; Lillian L Siu; Jeffrey S Hoch
Journal:  Cancer       Date:  2015-04-13       Impact factor: 6.860

3.  A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women.

Authors:  Elmar A Joura; Anna R Giuliano; Ole-Erik Iversen; Celine Bouchard; Constance Mao; Jesper Mehlsen; Edson D Moreira; Yuen Ngan; Lone Kjeld Petersen; Eduardo Lazcano-Ponce; Punnee Pitisuttithum; Jaime Alberto Restrepo; Gavin Stuart; Linn Woelber; Yuh Cheng Yang; Jack Cuzick; Suzanne M Garland; Warner Huh; Susanne K Kjaer; Oliver M Bautista; Ivan S F Chan; Joshua Chen; Richard Gesser; Erin Moeller; Michael Ritter; Scott Vuocolo; Alain Luxembourg
Journal:  N Engl J Med       Date:  2015-02-19       Impact factor: 91.245

4.  A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women.

Authors:  Darron R Brown; Marcia L Shew; Brahim Qadadri; Nicole Neptune; Maria Vargas; Wanzhu Tu; Beth E Juliar; Timothy E Breen; J Dennis Fortenberry
Journal:  J Infect Dis       Date:  2004-12-10       Impact factor: 5.226

5.  Long-term impact of human papillomavirus vaccination on infection rates, cervical abnormalities, and cancer incidence.

Authors:  Johannes A Bogaards; Veerle M H Coupé; Maria Xiridou; Chris J L M Meijer; Jacco Wallinga; Johannes Berkhof
Journal:  Epidemiology       Date:  2011-07       Impact factor: 4.822

6.  Exploring the Reasons Behind Parental Refusal of Vaccines.

Authors:  Chephra McKee; Kristin Bohannon
Journal:  J Pediatr Pharmacol Ther       Date:  2016 Mar-Apr

7.  The estimated direct medical cost of selected sexually transmitted infections in the United States, 2008.

Authors:  Kwame Owusu-Edusei; Harrell W Chesson; Thomas L Gift; Guoyu Tao; Reena Mahajan; Marie Cheryl Bañez Ocfemia; Charlotte K Kent
Journal:  Sex Transm Dis       Date:  2013-03       Impact factor: 2.830

8.  Estimates of the annual direct medical costs of the prevention and treatment of disease associated with human papillomavirus in the United States.

Authors:  Harrell W Chesson; Donatus U Ekwueme; Mona Saraiya; Meg Watson; Douglas R Lowy; Lauri E Markowitz
Journal:  Vaccine       Date:  2012-08-04       Impact factor: 3.641

9.  Parents' perceptions of provider communication regarding adolescent vaccines.

Authors:  Amanda F Dempsey; Jennifer Pyrzanowski; Steven Lockhart; Elizabeth Campagna; Juliana Barnard; Sean T O'Leary
Journal:  Hum Vaccin Immunother       Date:  2016-04-14       Impact factor: 3.452

Review 10.  Systematic Review and Meta-Analysis of Interventions to Improve Access and Coverage of Adolescent Immunizations.

Authors:  Jai K Das; Rehana A Salam; Ahmed Arshad; Zohra S Lassi; Zulfiqar A Bhutta
Journal:  J Adolesc Health       Date:  2016-10       Impact factor: 5.012

View more
  7 in total

1.  A multi-site case study of community-clinical linkages for promoting HPV vaccination.

Authors:  Heather M Brandt; Robin C Vanderpool; Susan J Curry; Paige Farris; Jason Daniel-Ulloa; Laura Seegmiller; Lindsay R Stradtman; Thuy Vu; Victoria Taylor; Maria Zubizarreta
Journal:  Hum Vaccin Immunother       Date:  2019-06-03       Impact factor: 3.452

Review 2.  The interface between U.S. primary care clinics and pharmacies for HPV vaccination delivery: A scoping literature review.

Authors:  Patricia A Carney; Sarah Bumatay; Grace M Kuo; Paul M Darden; Andrew Hamilton; Lyle J Fagnan; Brigit Hatch
Journal:  Prev Med Rep       Date:  2022-07-04

3.  The feasibility and acceptability of a pilot randomized controlled trial testing pharmacy-based HPV vaccine completion.

Authors:  Alexis Koskan; Morgan E Zittel; Chong Lee; Omar Sanchez; Linda Alvarez; Deborah L Helitzer
Journal:  Res Social Adm Pharm       Date:  2021-08-08

4.  Perceptions of HPV vaccination and pharmacist-physician collaboration models to improve HPV vaccination rates.

Authors:  Benjamin S Teeter; Catherine R Jensen; Jeremy L Thomas; Bradley C Martin; Pearl A McElfish; Cynthia L Mosley; Geoffrey M Curran
Journal:  Explor Res Clin Soc Pharm       Date:  2021-04-22

5.  Factors associated with human papillomavirus and meningococcal vaccination among adolescents living in rural and urban areas.

Authors:  Thomas G Boyce; Ben Christianson; Kayla E Hanson; Denise Dunn; Elizabeth Polter; Jeffrey J VanWormer; Charnetta L Williams; Edward A Belongia; Huong Q McLean
Journal:  Vaccine X       Date:  2022-06-11

6.  Leveraging teachable moments in cancer prevention by improving HPV vaccination in health professional students (HPS): A systematic review.

Authors:  Morgan S Levy; Lindsey Finch; Kara A Lindsay; Patricia Jeudin; Marilyn Huang
Journal:  Front Oncol       Date:  2022-08-29       Impact factor: 5.738

7.  Effects of Religious Practice and Teachings about Sexual Behavior on Intent to Vaccinate against Human Papillomavirus.

Authors:  David S Redd; Jamie L Jensen; Savannah J Hughes; Kendall Pogue; Chantel D Sloan-Aagard; Dashiell S Miner; Jessica D Altman; Triston B Crook; Lydia Zentz; Ruth J Bodily; Brian D Poole
Journal:  Vaccines (Basel)       Date:  2022-03-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.